BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.75 EUR
-0.72%
Market Closed
Updated:
May 18, 2024
BRAIN Biotech AG
Total Liabilities & Equity
|
BRAIN Biotech AG
Total Liabilities & Equity Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Total Liabilities & Equity
€66.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Total Liabilities & Equity
€9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Total Liabilities & Equity
€19.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Covestro AG
XETRA:1COV
|
Total Liabilities & Equity
€13.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Total Liabilities & Equity
€424.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Total Liabilities & Equity
€7.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
See Also
What is BRAIN Biotech AG's Total Liabilities & Equity?
Total Liabilities & Equity
66.5m
EUR
66.5m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Total Liabilities & Equity amounts to 66.5m EUR.
What is BRAIN Biotech AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
0%
0%
Over the last year, the Total Liabilities & Equity growth was -12%.
You don't have any saved screeners yet
